Sofinnova Investments, Inc. Pep Gen Inc. Transaction History

Sofinnova Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$10.54 - $18.14 $606,092 - $1.04 Million	57,504 Added 11.42%	561,128 $8.96 Million
Q1 2024 Aug 14, 2024	SELL	$6.63 - $17.3 $381,251 - $994,819	-57,504 Reduced 10.25%	503,624 $7.4 Million
Q1 2024 May 15, 2024	BUY	$6.63 - $17.3 $3.19 Million - $8.31 Million	480,586 Added 2086.06%	503,624 $7.4 Million
Q4 2023 Aug 15, 2024	SELL	$3.86 - $7.96 $2.08 Million - $4.28 Million	-538,090 Reduced 95.89%	23,038 $156,000
Q4 2023 Feb 12, 2024	BUY	$3.86 - $7.96 $88,926 - $183,382	23,038 New	23,038 $156,000

24.7M

15K

Ticker PEPG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,631,900
Market Cap $57.4M
Description
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.